Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People Briefs

This article was originally published in The Gray Sheet

Executive Summary

Israeli firm Insightec appoints former Mako Surgical co-founder and chair as CEO, ACell taps new president and CEO, and more personnel updates from JenaValve Technology, Zeltiq and Reva Medical.

You may also be interested in...



TAVR Evolution On Display At EuroPCR

Data on both new transcatheter aortic valve technologies and established TAVR devices were featured at this year’s EuroPCR meeting in Paris.

Stryker MAKO Purchase Could Preview Ortho’s Future

Market-leading orthopedic firms have mostly come up with incremental product updates in response to the growing tide of more technology-heavy upstarts. That is what makes Stryker’s $1.65 billion acquisition of MAKO Surgical stand out.

Reinvigorating The Coronary Stent Market: Can Bioresorbable Scaffolds Do The Job?

Bioresorbable coronary scaffolds could transform the coronary stenting market once they become widely available. But although there are more than a dozen companies developing these promising devices, there are still a number of unanswered questions – chief among them, how effectively they will compete against existing and upcoming next-generation durable stents, and how much of a price premium bioresorbable devices will be able to command.

Topics

Related Companies

UsernamePublicRestriction

Register

MT034901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel